Search hospitals > California > Fremont
Washington Hospital
Claim this profileFremont, California 94538
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Pathologic Constriction
33 reported clinical trials
2 medical researchers
Summary
Washington Hospital is a medical facility located in Fremont, California. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Adenocarcinoma, Pathologic Constriction and other specialties. Washington Hospital is involved with conducting 33 clinical trials across 54 conditions. There are 2 research doctors associated with this hospital, such as Bogdan S. Eftimie and Jes Alexander.Area of expertise
1Breast Cancer
Global LeaderHER2 positive
ER positive
ER negative
2Cancer
Global LeaderStage IV
HER2 positive
ER positive
Top PIs
Bogdan S. EftimieWashington Hospital3 years of reported clinical research
Studies Cancer
Studies Breast Cancer
11 reported clinical trials
35 drugs studied
Jes AlexanderWashington Hospital3 years of reported clinical research
Studies Prostate Adenocarcinoma
Studies Prostate Cancer
2 reported clinical trials
14 drugs studied
Clinical Trials running at Washington Hospital
Breast Cancer
Prostate Cancer
Lung Cancer
Rectal Cancer
Non-Small Cell Lung Cancer
Prostate Adenocarcinoma
Cancer
Lung Carcinoma
Adenocarcinoma
Recurrence
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Washington Hospital?
Washington Hospital is a medical facility located in Fremont, California. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Adenocarcinoma, Pathologic Constriction and other specialties. Washington Hospital is involved with conducting 33 clinical trials across 54 conditions. There are 2 research doctors associated with this hospital, such as Bogdan S. Eftimie and Jes Alexander.